NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yuval CohenChief Executive Officer2025-10-278,973$4.26
$38.22kBuy
Yuval CohenChief Executive Officer2025-10-278,973$17.14
$153.80kSell
Sean F. MoranChief Financial Officer2025-10-2412,981$17.02
$220.94kSell
Yuval CohenChief Executive Officer2025-10-2418,660$17.01
$317.41kSell
Yuval CohenChief Executive Officer2025-10-2418,660$4.26
$79.49kBuy
Sean F. MoranChief Financial Officer2025-10-2412,981$4.26
$55.30kBuy
Anne AltmeyerDirector2025-10-201,060$4.80
$5.09kBuy
Anne AltmeyerDirector2025-10-201,060$20.50
$21.73kSell
Anne AltmeyerDirector2025-05-301,392$7.25
$10.10kSell
John Kenneth JenkinsDirector2025-05-302,783$7.35
$20.47kSell

1 of 2

CRBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sumner Burstein20.48%3,594,571$38.43MInsider
Cormorant Asset Management LP16.05%2,817,368$30.12MInsider
Knoll Capital Management LP15.67%2,750,000$29.40MInsider
Cormorant Asset Management LP13.53%2,375,000$25.39MInstitution
Mark Tepper12.02%2,110,400$22.56MInsider
Orbimed Advisors LLC6.68%1,172,287$12.53MInstitution
Octagon Capital Advisors LP6.35%1,115,000$11.92MInstitution
David P. Hochman4.66%818,700$8.75MInsider
Vanguard Group Inc3.49%612,030$6.54MInstitution
Prosight Management LP1.96%343,400$3.67MInstitution

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP40.84%59.16%Net SellingNet Buying
RNAC12.84%87.16%Net BuyingNet Buying
NTHI8.71%91.29%Net BuyingNet Buying
CBIO13.64%86.36%
CRBU39.75%8.81%Net Buying

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 50.13% institutional shareholders, 72.64% Corbus Pharmaceuticals Holdings insiders, and 0.00% retail investors. Sumner Burstein is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 3.59M shares representing 20.48% of the company. Sumner Burstein's Corbus Pharmaceuticals Holdings shares are currently valued at $36.81M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.